Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 3, 2015
Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial
Louis Bazire, Isabelle Fromantin, Alhassane Diallo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2011
Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy
Romuald Le Scodan, Jessica Selz, Denise Stevens, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 23, 2010
DNA repair gene expression and risk of locoregional relapse in breast cancer patients
Romuald Le Scodan, Géraldine Cizeron-Clairac, Emmanuelle Fourme, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2019
Photons Without Bolus Versus Electrons With Bolus After Upfront Mastectomy Without Immediate Reconstruction in Breast Cancer Patients
Geoffroy Boulle, Caroline Saint-Martin, Brigitte De La Lande, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 23, 2010
Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
Caroline Daveau, Denise Stevens, Etienne Brain, et al.
Plos One
|
August 31, 2019
Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation
Alice Clément-Zhao, Marie-Laure Tanguy, Paul Cottu, et al.
International Journal of Cancer
|
August 12, 2023
CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancer
Sofiane Allali, Matthieu Carton, Sibille Everhard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 2006
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results
Jacques Rouëssé, Brigitte de la Lande, Frédérique Bertheault-Cvitkovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy
Romuald Le Scodan, Denise Stevens, Etienne Brain, et al.
Breast (Edinburgh, Scotland)
|
September 28, 2014
Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer
Victor Pernin, Lisa Belin, Paul Cottu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 3, 2015
Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial
Louis Bazire, Isabelle Fromantin, Alhassane Diallo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2011
Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy
Romuald Le Scodan, Jessica Selz, Denise Stevens, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 23, 2010
DNA repair gene expression and risk of locoregional relapse in breast cancer patients
Romuald Le Scodan, Géraldine Cizeron-Clairac, Emmanuelle Fourme, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2019
Photons Without Bolus Versus Electrons With Bolus After Upfront Mastectomy Without Immediate Reconstruction in Breast Cancer Patients
Geoffroy Boulle, Caroline Saint-Martin, Brigitte De La Lande, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 23, 2010
Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
Caroline Daveau, Denise Stevens, Etienne Brain, et al.
Plos One
|
August 31, 2019
Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation
Alice Clément-Zhao, Marie-Laure Tanguy, Paul Cottu, et al.
International Journal of Cancer
|
August 12, 2023
CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancer
Sofiane Allali, Matthieu Carton, Sibille Everhard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 2006
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results
Jacques Rouëssé, Brigitte de la Lande, Frédérique Bertheault-Cvitkovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy
Romuald Le Scodan, Denise Stevens, Etienne Brain, et al.
Breast (Edinburgh, Scotland)
|
September 28, 2014
Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer
Victor Pernin, Lisa Belin, Paul Cottu, et al.
Page
of 2